EN
HI
Summary
As of 31 Oct, 2026, Strides Pharma Science stock price is ₹1068.8. During the trading session, the stock has moved between an intraday low of ₹972.00 and an intraday high of ₹1076.90. Over the last 52 weeks, Strides Pharma Science has traded between ₹768.65 and ₹1260.90.
The stock has recorded a trading volume of 26,77,985 shares,. Its Average Traded Price (ATP) is ₹1023.00, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 50 @ ₹1068.80.
Strides Pharma Science has an upper circuit limit of ₹1317.00 and a lower circuit limit of ₹878.00. The total value traded stands at ₹273.96 CR, and the delivery percentage for the day is 44.33%.
The stock is currently traded with a market lot size of 1. Strides Pharma Science also offers a dividend yield of 0.46%.
Strides Pharma Science Share Price Chart
Strides Pharma Science Share Key Metrics
Volume
26.78 L
Market Cap
9851.42 CR
LTQ@LTP
50@1068.80
ATP
1023
Var Margin
19.46 %
Circuit Range
878-1317
Delivery %
44.33 %
Value
273.96 CR
ASM/GSM
No
Market Lot
1
Strides Pharma Science Fundamentals
P/E Ratio
16.49
P/B Ratio
3.09
Div. Yield
0.46
Sector P/E
39.93
Sector P/B
3.3
Sec. Div. Yield
0.53
Strides Pharma Science Resistance and Support
Pivot 1096.63
Resistance
First Resistance
1105.86
Second Resistance
1114.23
Third Resistance
1123.46
Support
First Support
1088.26
Second Support
1079.03
Third Support
1070.66
Strides Pharma Science Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Fri Oct 30 2026 | 1050 | 1068.8 | -2.62% | 1076.9 | 972 |
| Thu Oct 29 2026 | 1087.4 | 1097.5 | 1.10% | 1105 | 1087.4 |
| Wed Oct 28 2026 | 1093.3 | 1085.59 | -0.71% | 1109.9 | 1077.4 |
Strides Pharma Science Corporate Actions
| Date | Agenda |
|---|---|
| 2026-10-29 | Quarterly Results |
| 2026-07-31 | Quarterly Results |
| 2026-05-18 | Audited Results & Final Dividend |
| 2026-01-30 | Quarterly Results |
| 2025-10-31 | Quarterly Results |
| 2025-07-29 | Quarterly Results |
| 2025-05-22 | Audited Results & Final Dividend |
| 2025-01-30 | Quarterly Results |
| 2024-10-24 | Quarterly Results |
| 2024-07-29 | Quarterly Results |
Strides Pharma Science News
Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Strides Pharma Science reported Q2 FY27 revenue of Rs.1,429.7 crores (up 17% YoY) and net profit of Rs.134.1 crores (up 2% YoY). Ex-US markets grew 31% YoY to Rs.696.3 crores, surpassing the US business in quarterly revenue for the first time.
Oct 29 2026 18:54:18
Strides Pharma Science Ltd - 532531 - Board Meeting Intimation for Intimation Regarding Board Meeting Under Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Strides Pharma Science board to meet on October 29, 2026, for financial results. The meeting will focus on the performance for the quarter ended September 30, 2026.
Oct 23 2026 17:09:55
Strides Pharma Science Management
| Name | Position |
|---|---|
| Arun Kumar | Chairman |
| Kausalya Santhanam | Non Executive Independent Director |
Strides Pharma Science Similar Stocks
Rainbow Children's Medicare Ltd.
1218.70
21.90 (1.83%)
Akums Drugs & Pharmaceuticals Ltd.
731.70
-9.35 (1.26%)
Metropolis Healthcare Ltd.
545.65
-8.20 (1.48%)
Sanofi Consumer Healthcare India Ltd.
3442.30
-25.70 (0.74%)
Viyash Scientific Ltd.
218.39
-6.16 (2.74%)
Blue Jet Healthcare Ltd.
504.55
1.00 (0.20%)
Park Medi World Ltd.
219.70
-1.55 (0.70%)
Yatharth Hospital & Trauma Care Services Ltd.
926.90
3.60 (0.39%)
Healthcare Global Enterprises Ltd.
585.55
-5.90 (1.00%)
Procter & Gamble Health Ltd.
5670.50
157.00 (2.85%)
Strides Pharma Science FAQs
The Buying Price of Strides Pharma Science share is 1068.8 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Strides Pharma Science stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Strides Pharma Science, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Strides Pharma Science shares is 16.49. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Strides Pharma Science shares is 3.09. Useful to assess the stock's value relative to its book value.
To assess Strides Pharma Science’s valuation compare Sector P/E, P/B which are 39.93 & 3.3 with sector averages, along with growth rates and financial metrics.
The Market Cap of Strides Pharma Science is 9851.42 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Strides Pharma Science share price is 1260.90 & 768.65. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Strides Pharma Science belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in STAR
